Skip to content
10-K

Annual Report

AVENUE THERAPEUTICS, INC. ATXI

0001437749-25-010196

← back to feed
Filed
Mar 31, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 28, 2025 3.15M sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$9.45M
Cash And Equivalents FY 2024 · Dec 31, 2023 $1.78M
Stockholders Equity FY 2024 · Dec 31, 2023 $1.58M
Current Liabilities FY 2024 · Dec 31, 2023 $1.2M
Total Liabilities FY 2024 · Dec 31, 2023 $1.2M
Total Assets FY 2024 · Dec 31, 2023 $1.85M
Eps Basic restated FY 2024 · Dec 31, 2023 −$73.48
Sga Expense FY 2024 · Dec 31, 2023 $4.18M
Rd Expense FY 2024 · Dec 31, 2023 $6.13M
Operating Income FY 2024 · Dec 31, 2023 −$14.54M